May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Local macrophage depletion improves survival of corneal xenografts in mice by blocking antigen presentation and inhibiting hem– and lymphangiogenesis.
Author Affiliations & Notes
  • L.P. Borges
    Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • C. Cursiefen
    Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • J.W. Streilein
    Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships  L.P. Borges, None; C. Cursiefen, None; J.W. Streilein, None.
  • Footnotes
    Support  USPHS EY–10765
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 601. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.P. Borges, C. Cursiefen, J.W. Streilein; Local macrophage depletion improves survival of corneal xenografts in mice by blocking antigen presentation and inhibiting hem– and lymphangiogenesis. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):601.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: BALB/c mice reject orthotopic guinea pig corneas acutely (8–12 days) by a macrophage–dependent process triggered by specific CD4+ Th1 effector cells. We wished to determine which aspect(s) of macrophage function is (are) responsible for graft rejection. Methods: At the time that guinea pig corneas were grafted orthotopically into eyes of BALB/c mice, liposomes containing clodronate or PBS were injected subconjunctivally. Groups of recipients were examined subsequently as follows: at 12 hrs grafted eyes were enucleated from euthanized mice and the corneas stained for CD11b+, GR–1+ and F4/80+ cells; at 7 days corneas of grafted eyes of euthanized mice were stained for LYVE–1 and CD31 (markers of new blood and lymph vessels); xenografts in eyes of 10 recipients were evaluated clinically via slitlamp for evidence of irreversible rejection (opacity). Results: Few F4/80+ (but many CD11b+) cells were detected in the clodronate–treated xenograft beds within 12 hrs of grafting, and few if any CD31+ and/or LYVE–1+ endothelial cells were detected in these beds at 7 days. Corneal xenografts in clodronate treated eyes displayed opacity scores indicative of rejection between 20 and 23 days post grafting. Conclusions: Elimination of recruited macrophages suppresses angiogenesis and inhibits recipient sensitization to xenoantigens on cornea grafts. Together these macrophage–inhibitory effects promote the survival of corneal xenografts significantly.

Keywords: antigen presentation/processing • cornea: basic science • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×